Establishment Labs Holdings Inc.

Day range

$63.65 – $67.15

Open

$63.65

Prev close

$63.80

Volume

266.04K

Market cap

$1.9B

Shares out

29.8M

P/E

—

P/S

7.73

P/B

88.00

P/FCF

—

ROE

-180.0%

ROA

-11.1%

Debt/Equity

12.11

Div yield

0.00%

As of Oct 23, 2026

• Supply or distribution agreementOct 15, 2026

  On October 14, 2026, Establishment Labs Holdings Inc., through its wholly owned subsidiary, Establishment Labs, S.A., entered into Amendment No. 3 to the Master Supply Agreement with NuSil Technology LLC. Amendment No. 3 extends the end of the initial term of the Agreement from December 31, 2026, to December 31, 2031, with automatic renewal thereof for successive terms of one (1) year each for up to five (5) successive renewal terms.

• Executive compensation changeJun 29, 2026

  Effective April 24, 2026, the Board updated the non-employee director compensation policy to reflect an initial equity grant of $170,000 for new directors and a non-employee director annual grant of $170,000.

• Credit facilityApr 30, 2026

  On April 30, 2026, Establishment Labs Holdings Inc. entered into an Amended Credit Agreement and Guaranty with Lenders and Oaktree Fund Administration, LLC, as administrative agent, pursuant to which the Lenders agreed to make term loans to the Company in an aggregate principal amount of up to $300,000,000. The Credit Agreement amended and restated that certain Credit Agreement and Guaranty dated as of April 26, 2022.

• Investor presentationJan 14, 2026

  On January 14, 2026, Establishment Labs (the "Company") presented at the J.P. Morgan Healthcare Conference. The Company is furnishing presentation materials included as Exhibit 99.1 to this report pursuant to Item 7.01 of Form 8-K.

• Preliminary resultsJan 12, 2026

  On January 12, 2026, Establishment Labs Holdings Inc. (the "Company") issued a press release announcing the Company's preliminary unaudited financial information as of and for the quarter and year ended December 31, 2025.

Days to cover

12.1

Short interest

3.98M

Avg volume

329.83K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?
  positiveZacks Investment Research· Oct 22, 2026
• A Hedge Fund Dumped Establishment Labs Shares Worth $6.6 Million. Here's a Closer Look at the Transaction.
  positiveThe Motley Fool· Jul 5, 2026
• ESTA Founder Sells $7.9M on Earnings Day — Here's Why that's Not the Story
  positiveThe Motley Fool· May 11, 2026
• Breast Implants Market to Surpass USD 5.62 Billion by 2034, Driven by Rising Breast Cancer Cases and Aesthetic Surgery Demand
  positiveGlobeNewswire Inc.· Nov 11, 2025
• [Latest] Global Cosmetic Surgery Market Size/Share Worth USD 207.6 Billion by 2033 at a 11.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
  positiveGlobeNewswire Inc.· Jan 31, 2025